Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies Meeting Abstract

  

Authors:	Krebs, S.; Wolfe, J.; Mellinghoff, I.; Grommes, C.; Schoder, H.
Abstract Title:	Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies
Meeting Title:	32nd Annual Congress of the European Association of Nuclear Medicine (EANM'19)
Journal Title:	European Journal of Nuclear Medicine and Molecular Imaging
Volume:	46
Issue:	Suppl. 1
Meeting Dates:	2019 Oct 12-16
Meeting Location:	Barcelona, Spain
ISSN:	1619-7070
Publisher:	Springer
Date Published:	2019-10-01
Start Page:	S260
End Page:	S261
Language:	English
ACCESSION:	WOS:000492444402093
PROVIDER:	wos
PUBMED:	31535166
DOI:	10.1007/s00259-019-04486-2
Notes:	Meeting Abstract: OP-682 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/157379